Search Results

Article

The Office of Research Regulatory Affairs (ORRA)

Moving discoveries from bench to the best outcomes for children everywhere. The Abigail Wexner Research Institute at Nationwide Children’s Hospital enhances the health of children by engaging in high quality, cutting-edge research that results in better ways to prevent, screen for, diagnose

Article

GMP Facility

The cGMP Clinical Manufacturing Facility is located at Andelyn Biosciences, an affiliate company of Nationwide Children's Hospital.

Article

Our Innovation

Growing our own Cardiac Vessels Most doctors use plastic grafts to replace damaged arteries and blood vessels in children’s hearts. The problem is that organic hearts grow over time and synthetic plastics do not. To solve this, Dr. Christopher Breuer and Dr.

Article

Our Services

Consulting Our team currently provides regulatory affairs support and consulting for numerous academic, private, and publically traded programs working towards clinical development of AAV-based gene and cell-based therapies.

Meet Our Faculty

Article

Application

Eligibility Applications will be accepted from both MD physician-scientists and PhD applicants with training in health, psychology, epidemiology, or related fields.

Article

High Performance Computing

About Us The High Performance Computing (HPC) group opened in July 2015, and operates the Baker compute cluster, named for Dr. Sarah Josephine Baker. High Performance Computing supports researchers by providing computational resources for analysis and simulation of datasets ranging in size from

Article

National Health IT Week

For the second time, Nationwide Children's Hospital celebrated National Health IT Week to show how Information Technology employees are helping transform healthcare at Nationwide Children's Hospital.

Article

Biologics Manufacturing

Biologics Manufacturing maintains facilities, equipment and personnel for manufacturing a wide range of cellular therapeutic products for clinical trials including natural killer (NK) cells, CAR NK and CAR T cells and a tissue engineered vascular graft.